Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 17, 2021 Filed May 19, 2021 20:31 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 8,135 $89.49 $728,001.15
Disclosure

SEC source: 0001225208-21-008306 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,071.5231

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 1,772 $89.49 $158,576.28
Disclosure

SEC source: 0001225208-21-008306 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,206.5231

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 16,406 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008306 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,978.5231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Exercise / conversionPerformance Rights · Derivative 10,631 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008307 · doc4.xml · derivative · entry 4

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,631 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Tax withholdingCommon Stock 623 $89.49 $55,752.27
Disclosure

SEC source: 0001225208-21-008307 · doc4.xml · nonDerivative · entry 3

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,062.138

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Tax withholdingCommon Stock 143 $89.49 $12,797.07
Disclosure

SEC source: 0001225208-21-008307 · doc4.xml · nonDerivative · entry 2

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,685.138

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Exercise / conversionCommon Stock 10,631 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008307 · doc4.xml · nonDerivative · entry 1

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,828.138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionPerformance Rights · Derivative 15,225 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008305 · doc4.xml · derivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,225 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 7,549 $89.49 $675,560.01
Disclosure

SEC source: 0001225208-21-008305 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,431.2148

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 1,729 $89.49 $154,728.21
Disclosure

SEC source: 0001225208-21-008305 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,980.2148

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 15,225 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008305 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,709.2148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
SELLERS ROBERT W.A.VP, Corporate Controller
Tax withholdingCommon Stock 204 $89.49 $18,255.96
Disclosure

SEC source: 0001225208-21-008304 · doc4.xml · nonDerivative · entry 1

SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,555.6925

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionPerformance Rights · Derivative 8,662 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008302 · doc4.xml · derivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,662 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 4,295 $89.49 $384,359.55
Disclosure

SEC source: 0001225208-21-008302 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,889.8064

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 938 $89.49 $83,941.62
Disclosure

SEC source: 0001225208-21-008302 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,184.8064

Read SEC document
May 17, 2021 Filed May 19, 2021 20:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 8,662 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008302 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,122.8064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionPerformance Rights · Derivative 17,193 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008301 · doc4.xml · derivative · entry 5

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,193 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 8,525 $89.49 $762,902.25
Disclosure

SEC source: 0001225208-21-008301 · doc4.xml · nonDerivative · entry 3

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,131

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 1,643 $89.49 $147,032.07
Disclosure

SEC source: 0001225208-21-008301 · doc4.xml · nonDerivative · entry 2

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,656

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionCommon Stock 17,193 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008301 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionPerformance Rights · Derivative 15,750 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008300 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,750 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Tax withholdingCommon Stock 7,809 $89.49 $698,827.41
Disclosure

SEC source: 0001225208-21-008300 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,374.8505

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Tax withholdingCommon Stock 1,701 $89.49 $152,222.49
Disclosure

SEC source: 0001225208-21-008300 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,183.8505

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 15,750 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008300 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,884.8505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionPerformance Rights · Derivative 69,562 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008299 · doc4.xml · derivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 69,562 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:30 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 69,562 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-008299 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,001.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Tax withholdingCommon Stock 143 $90.40 $12,927.20
Disclosure

SEC source: 0001225208-21-008063 · doc4.xml · nonDerivative · entry 1

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,197.138

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 2,106 $90.40 $190,382.40
Disclosure

SEC source: 0001225208-21-008062 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,572.5231

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 2,028 $90.40 $183,331.20
Disclosure

SEC source: 0001225208-21-008061 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,484.2148

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
SELLERS ROBERT W.A.VP, Corporate Controller
Tax withholdingCommon Stock 274 $90.40 $24,769.60
Disclosure

SEC source: 0001225208-21-008060 · doc4.xml · nonDerivative · entry 1

SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,759.6925

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Tax withholdingCommon Stock 2,106 $90.40 $190,382.40
Disclosure

SEC source: 0001225208-21-008059 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,134.8505

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 1,090 $90.40 $98,536.00
Disclosure

SEC source: 0001225208-21-008058 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,460.8064

Read SEC document
May 11, 2021 Filed May 13, 2021 01:38 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 1,570 $90.40 $141,928.00
Disclosure

SEC source: 0001225208-21-008057 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,106

Read SEC document
May 10, 2021 Filed May 11, 2021 14:03 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,830 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-21-007899 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,810

Underlying: Common Stock · 7,830 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2021 Filed May 11, 2021 14:03 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 7,830 $92.22 $722,082.60
Disclosure

SEC source: 0001225208-21-007899 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,678.5231

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Read SEC document
May 10, 2021 Filed May 11, 2021 14:03 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,830 $35.20 $275,590.16
Disclosure

SEC source: 0001225208-21-007899 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,508.5231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-007764 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,550

Underlying: Common Stock · 11,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 7,184 $92.14 $661,920.83
Disclosure

SEC source: 0001225208-21-007764 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,844.8505

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $91.8000 to $92.7900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 3,866 $93.23 $360,411.33
Disclosure

SEC source: 0001225208-21-007764 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,028.8505

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $92.8600 to $93.6100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 11,050 $21.76 $240,448.00
Disclosure

SEC source: 0001225208-21-007764 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,894.8505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 3,389 $0.00 Strike: $22.29 $0.00
Disclosure

SEC source: 0001225208-21-007763 · doc4.xml · derivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,410

Underlying: Common Stock · 3,389 shares

Expires 2022-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 3,389 $91.87 $311,347.43
Disclosure

SEC source: 0001225208-21-007763 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,940.2148

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:32 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 3,389 $22.29 $75,529.63
Disclosure

SEC source: 0001225208-21-007763 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,329.2148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,350 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-007762 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,150

Underlying: Common Stock · 6,350 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 6,350 $91.87 $583,374.50
Disclosure

SEC source: 0001225208-21-007762 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,912.8064

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:31 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 6,350 $21.76 $138,176.00
Disclosure

SEC source: 0001225208-21-007762 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,262.8064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:30 UTC GrantCommon Stock 818 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007755 · doc4.xml · nonDerivative · entry 2

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,433

F2 · shares: This restricted stock was granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Read SEC document
May 07, 2021 Filed May 7, 2021 22:30 UTC GrantCommon Stock 2,615 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007755 · doc4.xml · nonDerivative · entry 1

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,615

F1 · shares: These restricted stock units were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on the Issuer's Board.

Read SEC document
May 07, 2021 Filed May 11, 2021 21:15 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 538 $91.75 $49,361.50
Disclosure

SEC source: 0001225208-21-007975 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,676

Read SEC document
May 07, 2021 Filed May 11, 2021 21:14 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 362 $91.75 $33,213.50
Disclosure

SEC source: 0001225208-21-007974 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,900.8064

F1 · balance_after: Does not reflect transactions effected on May 7, 2021 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021, which transactions were reported on a Form 4 filed with the SEC on May 7, 2021. The actual amount of securities beneficially owned by the Reporting Person following transaction reported on this Form 4 is 95,550.8064.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.